ArticleEBioMedicine2023

An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.